Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.06 (+7.89%)
At close: Aug 19, 2026 · 4:00 PM EDT

Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Total Non-Current Liabilities came in at $856.5 million in Q1 2026, down 2.15% YoY from $875.3 million in Q1 2025, and up 1.4% on a QoQ basis from $844.6 million in Q4 2025.

Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Total Non-Current Liabilities data on file, last reported at $856.5 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 2.15% year-over-year to $856.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $856.5 million (down 2.15% YoY) and the FY2025 annual result came in at $844.6 million, down 3.23% from the prior year.
  • Total Non-Current Liabilities improved to $856.5 million in Q1 2026, from $844.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $885.5 million in Q2 2025 to a low of $689.2 million in Q2 2022.
  • A 5-year average of $784.0 million and a median of $740.1 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 64.23% — and 2025, when it slipped 3.23%.
  • Tracing CRLBF's Total Non-Current Liabilities over 5 years: stood at $740.1 million in 2022, then dropped by 1.35% to $730.2 million in 2023, then gained by 19.54% to $872.8 million in 2024, then dropped by 3.23% to $844.6 million in 2025, then gained by 1.4% to $856.5 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $856.5 million (Q1 2026), $844.6 million (Q4 2025), and $842.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 334.00 Mn
10 Cresco Labs 290.46 Mn 226.34 Mn 86.95 Mn 862.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 856.48 Mn
Dec 31, 2025 844.62 Mn
Sep 30, 2025 842.79 Mn
Jun 30, 2025 885.52 Mn
Mar 31, 2025 875.34 Mn
Dec 31, 2024 872.84 Mn
Sep 30, 2024 859.00 Mn
Jun 30, 2024 846.66 Mn
Mar 31, 2024 730.94 Mn
Dec 31, 2023 730.16 Mn
Sep 30, 2023 712.41 Mn
Jun 30, 2023 726.61 Mn
Mar 31, 2023 710.63 Mn
Dec 31, 2022 740.14 Mn
Sep 30, 2022 714.28 Mn
Jun 30, 2022 689.20 Mn
Mar 31, 2022 690.00 Mn
Dec 31, 2021 694.33 Mn
Sep 30, 2021 648.42 Mn
Mar 31, 2021 420.14 Mn